Surgical Site Infection Diagnosis and Management

By Dr. Zubair Khalid, DVM, MS, PhD ·

Surgical Site Infection Diagnosis and Management

Key Takeaways

  • Distinguishing surgical site infection (SSI) from expected postoperative inflammation hinges on timing; erythema and swelling persisting or worsening beyond 48-72 hours postoperatively strongly suggest infection over trauma.
  • Diagnostic sampling requires meticulous technique; percutaneous aspiration of intact exudate or tissue biopsy from the wound bed yields superior culture results compared to surface swabs, which often recover contaminants.
  • Deep incisional and organ-space infections necessitate aggressive management beyond antimicrobials, including surgical debridement of necrotic tissue, drainage of purulent material, and often removal of foreign bodies or implants to achieve resolution.
  • Empirical antimicrobial therapy should be guided by the suspected pathogen spectrum based on the surgical site (e.g., staphylococci for clean wounds, enteric organisms for abdominal procedures) and depth of infection, with broad-spectrum coverage initiated promptly for deep or systemic infections.
  • Imaging modalities like ultrasonography and CT are crucial for defining the extent of deep infections, identifying abscesses, foreign material, and guiding interventions, but findings must be interpreted cautiously in the early postoperative period due to overlapping inflammatory changes.
  • Host factors such as diabetes, immunosuppression, and the presence of implants significantly increase SSI risk and alter treatment thresholds, often necessitating earlier and more aggressive surgical intervention in conjunction with prolonged antimicrobial therapy.

Surgical site infections (SSIs) represent a distinct category of postoperative morbidity with diagnostic and therapeutic logic that differs from community-acquired infections. This article provides a diagnostic-reasoning framework for the practicing veterinarian confronting suspected SSI across companion animal, equine, and production animal patients. It covers clinical recognition, sampling strategy, microbiological interpretation, and therapeutic decision-making for superficial incisional, deep incisional, and organ-space infections. Prevention protocols, including perioperative antimicrobial prophylaxis and aseptic technique, are addressed in a separate article.

The central clinical question is whether postoperative inflammation represents expected surgical trauma or active infection requiring intervention. That distinction drives decisions about antimicrobial therapy, surgical exploration, and prognosis. The diagnostic approach must integrate timing, physical examination findings, host risk factors, and laboratory data, because no single test reliably discriminates infection from sterile inflammation in the early postoperative period.

At a Glance

ParameterClinical Decision Point
Timing of onsetErythema and swelling peaking beyond 48 to 72 hours postoperatively favor infection over traumatic inflammation
Discharge characterPurulent exudate, particularly with odor or color change, warrants sampling and empirical therapy
Depth of involvementFascial integrity determines superficial versus deep infection and changes surgical urgency
Systemic signsFever, lethargy, or anorexia shift management toward early exploration and broader-spectrum therapy
Sampling methodAspiration of intact exudate or tissue biopsy outperforms surface swabs for culture yield
Culture interpretationGrowth of known pathogens with compatible Gram stain supports infection, single colonies of commensals may represent contamination
Imaging roleUltrasonography and CT define abscess extent, foreign material, and deep tissue involvement
Host factorsDiabetes, immunosuppression, implants, and malnutrition increase infection risk and alter treatment thresholds

Pathophysiology of Surgical Site Infection

SSI develops when microbial contamination of the surgical wound overcomes local and systemic host defenses. The inoculum size, microbial virulence, and the presence of foreign material or devitalized tissue determine whether contamination progresses to clinical infection. Most SSIs originate from the patient's own skin flora, with staphylococci and streptococci predominating in companion animals, while enteric organizms feature more heavily in abdominal and perineal procedures.

The first 48 hours represent a critical window. During this period, the inflammatory response to surgical trauma produces erythema, edema, and heat that can mimic infection. Fibrin deposition and neutrophil recruitment begin immediately, and the wound's ability to contain bacterial proliferation depends on adequate perfusion, oxygenation, and the absence of necrotic debris. Implants, including orthopedic hardware and mesh, create a biofilm environment that shields bacteria from both immune effectors and systemically administered antimicrobials. As noted in the human osteomyelitis literature, the presence of necrotic bone or implanted material fundamentally changes the likelihood that antibiotics alone will achieve remission, and surgical resection or debridement becomes a component of definitive therapy Rao, Ziran, and Lipsky on osteomyelitis management.

Clinical Recognition and Diagnostic Criteria

Recognition begins with systematic wound assessment at defined postoperative intervals. The American College of Veterinary Surgeons emphasizes that owners should monitor incisions for swelling, discharge, and opening of the wound edges, and that veterinarians should distinguish these findings from normal healing ACVS animal health resources on surgical conditions. A wound that appears quiescent at 24 hours and then develops progressive erythema, heat, or exudate at 72 hours or later is more concerning than one with immediate postoperative inflammation that steadily improves.

Superficial incisional infections involve the skin and subcutaneous tissue only. Deep incisional infections extend to fascia and muscle. Organ-space infections involve any anatomic structure opened or manipulated during the procedure. This classification, adapted from human surveillance systems, guides both prognosis and therapeutic aggressiveness. Deep infections and organ-space infections require drainage and often surgical debridement, whereas superficial infections may respond to local care and systemic antimicrobials alone.

Systemic signs should be assessed at every postoperative examination. Fever beyond 48 hours postoperatively, particularly when accompanied by lethargy or inappetence, raises the index of suspicion. However, the acute phase protein response to surgery itself produces measurable systemic changes, and the magnitude and duration of this response varies by species and procedure Murata, Shimada, and Yoshioka on acute phase proteins in veterinary diagnosis. A single temperature measurement is insufficient, the trajectory of clinical signs matters more than any isolated value.

Diagnostic Sampling and Laboratory Interpretation

Sampling technique determines whether culture results guide therapy or mislead it. Surface swabs of draining tracts recover colonizing organizms and environmental contaminants more often than the true pathogen. The preferred approach is percutaneous aspiration of intact exudate or fluid pockets, performed after skin preparation to avoid contamination. When no fluid is aspirable, a tissue biopsy from the deep margin of the wound provides superior diagnostic yield. Samples should be submitted for both aerobic and anaerobic culture, because polymicrobial infections, particularly those involving enteric flora, frequently include obligate anaerobes.

Gram stain should be requested on all samples. The morphology and staining characteriztics of organizms provide immediate guidance for empirical antimicrobial selection while culture and susceptibility results are pending. A Gram stain showing gram-positive cocci in clusters supports antistaphylococcal therapy, whereas mixed gram-negative and anaerobic morphology suggests enteric contamination requiring broader coverage.

Culture interpretation requires clinical correlation. Growth of a single pathogen in pure culture from an aspirate is diagnostically meaningful. Growth of multiple organizms, or growth of typical skin commensals such as coagulase-negative staphylococci, may represent contamination, particularly if the sample was obtained through a draining tract. The laboratory report should be interpreted in the context of the Gram stain, the clinical presentation, and the sampling method. Molecular methods, including polymerase chain reaction, offer faster identification in some settings but do not provide susceptibility data and may detect nonviable organizms.

Imaging and Adjunctive Diagnostics

Ultrasonography is the most accessible imaging modality for evaluating superficial and deep incisional infections. It distinguishes fluid collections from solid swelling, identifies the extent of subcutaneous involvement, and guides aspiration. Computed tomography provides superior definition of deep infections, particularly in the thorax, abdomen, and paravertebral regions, and is indicated when organ-space infection is suspected or when the depth of involvement is unclear from physical examination.

Imaging findings must be interpreted with caution in the early postoperative period. Postsurgical fluid, edema, and inflammation produce sonographic and tomographic changes that overlap with infection. The presence of gas within soft tissues, a defined abscess capsule, or a foreign body increases diagnostic confidence. Serial imaging showing progression of fluid accumulation or tissue destruction supports infection over sterile inflammation.

Therapeutic Decision-Making

The decision to initiate antimicrobial therapy should follow, not precede, diagnostic sampling whenever the patient is stable enough to permit it. Empirical therapy is guided by the suspected pathogen spectrum, the depth of infection, and the presence of implants. For superficial infections in otherwise healthy patients, targeted therapy based on culture results is appropriate. For deep infections, organ-space infections, or infections in immunocompromised hosts, empirical broad-spectrum coverage should begin immediately after sampling and be refined once susceptibility data are available.

Antimicrobial therapy alone is insufficient for most deep infections. Drainage of purulent material, debridement of necrotic tissue, and removal of infected implants are the definitive therapeutic interventions. The human literature on osteomyelitis makes this point explicitly: chronic infection accompanied by necrotic bone usually requires surgical therapy, and antibiotic treatment without resection must be prolonged, typically four to six weeks or longer Rao, Ziran, and Lipsky on osteomyelitis management. The same principle applies to infected surgical sites in veterinary patients. A wound that does not respond to appropriate antimicrobial therapy within 48 to 72 hours should be explored surgically instead of subjected to additional antibiotic trials.

The duration of therapy depends on the depth of infection, the causative organizm, and the completeness of surgical debridement. Superficial infections may require only 7 to 14 days of therapy. Deep infections and those involving bone or implants require weeks of treatment, and the endpoint of therapy should be clinical resolution instead of a fixed duration. Current formulary and label references must be consulted for species-specific dosing, and withdrawal periods must be observed in food-producing animals.

Diagnostic Algorithm for Suspected Surgical Site Infection

The diagnostic sequence begins with a structured assessment that separates true infection from the normal inflammatory response to surgery. Serosanguineous discharge, mild edema, and erythema are expected in the first 48 to 72 hours postoperatively. Infection should be suspected when these findings intensify instead of resolve, when discharge becomes purulent, or when systemic signs develop after an initial period of improvement.

The algorithm proceeds through four decision gates:

  1. Clinical suspicion. Pain out of proportion to the procedure, progressive swelling, wound dehiscence, or malodorous discharge triggers formal evaluation.
  2. Depth classification. Determine whether the process is superficial (skin and subcutaneous tissue), deep incisional (muscle and fascia), or organ or space infection. This distinction drives sampling strategy and therapeutic intensity.
  3. Microbial confirmation. Obtain samples before starting antimicrobial therapy whenever possible.
  4. Host and wound assessment. Evaluate perfusion, foreign material, dead space, and immune status to determine whether surgery is required in addition to medical therapy.

Distinguishing Infection from Other Wound Complications

Seromas and hematomas produce fluctuant swelling without the progressive erythema, pain, or systemic signs typical of infection. Seroma fluid is typically clear to straw-colored and sterile on culture. A hematoma may show ecchymosis and is often associated with a discrete traumatic event or coagulopathy. Both can become secondarily infected, so aspiration with cytology and culture is indicated when clinical distinction is unclear.

Wound dehiscence without purulent discharge may reflect technical failure, excessive tension, or self-trauma instead of infection. However, any open wound should be cultured at the time of assessment, because bacterial colonization of exposed tissue is rapid and may influence closure decisions.

Suture reactions produce focal erythema and discharge at suture tracts, usually within 10 to 14 days of surgery. The discharge is typically serous or serosanguineous, and cytology shows mixed inflammation without bacteria. Removal of the offending suture material is both diagnostic and therapeutic.

Decision Points That Change the Diagnostic Path

The presence of systemic signs, including fever, lethargy, or hypotension, mandates blood culture collection and immediate empirical therapy. In immunocompromised patients, including those receiving chemotherapy or long-term glucocorticoids, the inflammatory response may be blunted. Erythema and purulent discharge may be minimal despite deep infection, and imaging should be pursued earlier in these patients.

Patients with implants, including orthopedic hardware, mesh, or vascular access devices, require a different threshold for intervention. Infection in the presence of foreign material rarely resolves with antimicrobial therapy alone, and the diagnostic workup should include assessment of implant stability and planning for possible removal. The same principle applies to bone involvement, where surgical resection of infected bone is often required for remission.

Sampling Technique and Culture Strategy

Superficial Infections

For superficial incisional infections, the wound should be clipped and prepared with chlorhexidine or povidone-iodine. The surface should be allowed to dry, and a sterile swab should be inserted into the deepest portion of the wound or sinus tract. Surface swabs of draining tracts frequently recover contaminants and may miss the primary pathogen. Aspiration of intact abscesses or fluid pockets with a sterile needle and syringe provides superior specimens.

Deep Infections

Deep incisional and organ or space infections require sampling under aseptic conditions, often with sedation or general anesthesia. Ultrasound guidance improves the accuracy of aspiration for fluid collections deep to the body wall. Tissue biopsy is preferred over swabs when available, because tissue samples yield higher organizm recovery rates and allow histopathologic assessment of tissue invasion.

For suspected osteomyelitis, bone biopsy through unaffected tissue is the reference standard. Sinus tract cultures correlate poorly with deep bone isolates, and antimicrobial selection based on superficial cultures risks undertreatment of resistant organizms. Chronic osteomyelitis with necrotic bone requires surgical debridement in addition to culture-directed therapy.

Specimen Handling

Aerobic and anaerobic culture media should be inoculated at the time of collection. Anaerobic transport media are required if processing is delayed beyond 30 minutes. Blood culture bottles can be used for fluid specimens to improve organizm recovery, particularly when the sample volume is small or the patient has received prior antimicrobial therapy.

Gram stain should be performed on all aspirates and tissue imprints. The presence of bacteria on Gram stain confirms infection even before culture results are available and guides initial antimicrobial selection. Cytology should also assess for fungal elements, particularly in patients with risk factors for opportunistic infection. Invasive fungal infections require a high index of suspicion and are confirmed by histopathology and culture, as diagnosis depends on evaluation with histopathology, culture, and increasingly molecular identification.

Treatment Decision Framework

Infection ClassificationPrimary TherapySurgical RoleAntimicrobial DurationMonitoring
Superficial, no systemic signsEmpirical broad-spectrum oral therapyDrainage if abscess present7 to 10 days, extend if clinical response incompleteWound assessment every 48 hours
Superficial, systemic signsParenteral empirical therapy, adjust to cultureDrainage and debridement10 to 14 daysTemperature, wound, appetite daily
Deep incisionalParenteral therapy, culture-directedDebridement of necrotic tissue, drain placement14 to 21 daysSerial wound assessment, imaging if no response
Organ or space infectionParenteral therapy, culture-directedSource control, lavage, drainage21 to 28 days or longerSerial imaging, inflammatory markers
Implant-associatedParenteral therapy, culture-directedImplant removal or exchange4 to 6 weeks after implant removalRadiographic assessment, long-term follow-up
OsteomyelitisParenteral therapy, culture-directedDebridement of all necrotic bone4 to 6 weeks minimum after debridementSerial imaging, inflammatory markers

Antimicrobial Selection Principles

Empirical therapy should cover the most likely pathogens for the procedure and anatomic site. Skin and soft tissue infections after clean procedures are most commonly caused by staphylococci, and therapy should include activity against methicillin-resistant strains when local prevalence is high. Antimicrobial therapy is complicated by the increasing prevalence of antibiotic-resistant organizms, especially methicillin-resistant Staphylococcus aureus.

Gastrointestinal or urogenital procedures broaden the differential to include enteric gram-negative organizms and anaerobes. Combination therapy or a single agent with appropriate spectrum is selected based on the procedure type and local resistance patterns.

Current formulary and label references must be consulted for doses, routes, and withdrawal periods. Doses vary by species, and production animals require attention to labeled withdrawal intervals. Regional regulatory requirements may restrict the use of certain antimicrobial classes, and practitioners should verify professional practice guidance from their regional veterinary body before prescribing.

The Role of Surgery

Antimicrobial therapy alone is insufficient when necrotic tissue, foreign material, or undrained purulent collections are present. Surgical debridement removes the bacterial burden and the devitalized tissue that supports ongoing infection. All necrotic tissue should be excised until viable, bleeding tissue is encountered. The wound should be lavaged copiously with sterile saline, and drains should be placed when dead space remains.

For osteomyelitis, antibiotic treatment without surgical resection of infected bone must be prolonged to at least 4 to 6 weeks, and surgical debridement improves the likelihood of remission. Implant-associated infections require removal of the hardware for cure in most cases, although suppressive therapy may be considered when removal is not feasible.

Monitoring Parameters and Response Assessment

Clinical response is assessed through daily evaluation of wound appearance, pain scores, temperature, and appetite. A reduction in erythema, swelling, and discharge over 48 to 72 hours indicates appropriate therapy. Lack of response within this window prompts reassessment of the diagnosis, culture results, and the possibility of undrained infection.

Serial measurement of acute phase proteins, including C-reactive protein and serum amyloid A, can support monitoring of treatment response, although the clinical utility of acute phase protein monitoring varies by species and assay availability. These markers are more useful for confirming resolution than for establishing the initial diagnosis.

Imaging is repeated when deep infection fails to respond to appropriate therapy. Ultrasonography identifies undrained fluid collections, while computed tomography or magnetic resonance imaging is indicated for suspected osteomyelitis or mediastinal involvement. Early diagnosis with computed tomography is critical in aggressive infections that spread through anatomic fascial planes.

Documentation and Communication

The medical record should document the date of onset, clinical findings, depth classification, sampling method, culture results, antimicrobial therapy with rationale, surgical interventions, and the monitoring plan. Photographs of the wound at initial assessment and at each recheck provide objective documentation of progression.

Owners should be informed of the expected timeline for response, the importance of completing the full antimicrobial course, and the signs that warrant immediate re-evaluation. Patients with deep or implant-associated infections require long-term follow-up, because recurrence can occur months after apparent resolution.

Recognized Complications and Failure Modes

The most consequential failure in surgical site infection management is undertreated deep infection mistaken for superficial cellulitis. A wound that appears superficially erythematous but sits over an implant, a body cavity, or a fascial plane can harbour infection that will not respond to surface-level intervention. Early detection depends on serial assessment instead of a single examination. Compare the wound at 24, 48, and 72 hours postoperatively. Progressive swelling, worsening pain on palpation, or new drainage after day 3 should raise suspicion beyond simple superficial infection.

Implant-associated infection represents a distinct failure mode. Biofilm formation renders culture results unreliable and antimicrobial therapy alone insufficient. When a bone plate, prosthetic ligament, or mesh is present, persistent drainage or sinus tract formation weeks after surgery indicates biofilm-related infection. Rao, Ziran, and Lipsky describe the requirement for surgical resection of infected bone in chronic osteomyelitis, and the same principle applies to infected implants: the foreign material must be removed or exchanged for remission to be achieved.

Necrotising infection is the most time-critical failure. Rapidly expanding erythema, violaceous discolouration, crepitus, severe pain out of proportion to examination, or systemic deterioration mandate immediate surgical exploration. Sancho and colleagues document the progression of cervical infections to descending necrotising mediastinitis, illustrating how deep fascial infection can spread along anatomic planes with devastating consequences. In veterinary patients, the analogous risk is extension from a cervical or inguinal wound into the thorax or abdomen.

Fungal infection is an under-recognized failure mode, particularly in immunocompromised patients or those with prolonged antimicrobial exposure. Mucormycosis requires a high index of suspicion and evaluation with histopathology, culture, and molecular identification. When a wound fails to improve despite appropriate antibacterial therapy, fungal culture and tissue biopsy should be considered instead of repeated antibacterial courses.

Common Errors and Corrective Actions

The most frequent error is sampling the wrong site. Swabbing purulent discharge from the wound surface recovers contaminants and skin commensals, not the infecting organizm. The corrective action is to aspirate fluid from deep within the wound or collect tissue from the wound bed after surface debridement. A second common error is submitting samples before any antimicrobial therapy is initiated, then starting antibiotics before culture results return. The correct sequence is sampling first, then therapy, with the understanding that empirical coverage may need revision once susceptibility data are available.

A third error is interpreting a single negative culture as exclusion of infection. Prior antimicrobial exposure, inadequate sample volume, or fastidious organizms all produce false negatives. The diagnostic limitations of culture-dependent methods are recognized in human prosthetic valve endocarditis, where molecular diagnostics have improved detection. In veterinary practice, if clinical signs persist despite a negative culture, repeat sampling with tissue instead of swabs is indicated.

Students and less experienced clinicians often mistake postoperative inflammation for infection. Seroma, suture reaction, and tissue trauma from retraction all produce warmth and swelling. The discriminating feature is progression: inflammation stabilizes or improves by day 3, while infection worsens. Fever, lethargy, and neutrophilia with left shift support infection, but their absence does not exclude it, particularly in immunocompromised patients.

Troubleshooting Table

ObservationLikely causeDiscriminating check
Erythema stabilizing by day 3Surgical inflammationNo progression, no purulent drainage, normal appetite
Erythema expanding after day 3Superficial infectionPurulent drainage, positive culture from deep sample
Sinus tract over implant siteBiofilm-associated infectionImaging for implant loosening, surgical exploration
Rapid swelling with discolourationNecrotising infectionImmediate surgical exploration, histopathology
Wound fails to improve on appropriate antibioticsResistant organizm, fungal infection, or foreign bodyRepeat culture with tissue sample, imaging, biopsy
Negative culture with persistent clinical signsPrior antimicrobial exposure, fastidious organizmTissue biopsy, molecular diagnostics, hold antibiotics before resampling

Evidence Limitations and Referral Criteria

The evidence base for veterinary surgical site infection management is largely extrapolated from human medicine and small case series. Acute phase protein monitoring has been investigated as a diagnostic adjunct in veterinary patients, but its role in routine postoperative monitoring remains undefined. Expert opinion differs on the duration of antimicrobial therapy for deep infections, with recommendations ranging from weeks to months depending on the presence of implants and bone involvement. Rao and colleagues note that without surgical resection of infected bone, antibiotic treatment must be prolonged for at least 4 to 6 weeks, but this figure derives from human data and may not transfer directly across species.

Referral is warranted when infection involves bone, joints, or body cavities, when implants are present, when necrotising infection is suspected, or when the patient deteriorates despite appropriate therapy. Specialist consultation is also appropriate when repeated cultures are negative but clinical signs persist. The American College of Veterinary Surgeons provides specialist resources on surgical conditions and expected outcomes that can guide referral decisions. Laboratory involvement is indicated for histopathology when neoplasia or fungal infection is in the differential, and for susceptibility testing when resistant organizms are suspected.

Regulatory reporting obligations vary by jurisdiction and production system. The World Organization for Animal Health maintains international standards for disease surveillance and reporting, and the American Veterinary Medical Association provides practice resources on professional obligations. Clinicians should be aware that certain multidrug-resistant organizms may carry reporting requirements in their region, and that food animal infections may trigger withdrawal period considerations that differ from companion animal practice.

Frequently Asked Questions

How Should I Manage a Suspected Surgical Site Infection When Culture and Sensitivity Testing Is Not Available or Affordable?

When laboratory access is limited, base antimicrobial selection on expected pathogens, local resistance patterns, and infection depth. Superficial infections with purulent discharge often respond to first-line agents targeting common skin flora. Deep infections, particularly those involving bone or implants, carry higher risk of resistant organizms such as methicillin-resistant Staphylococcus aureus, and empirical therapy must account for this possibility. The evidence supporting prolonged antibiotic courses for osteomyelitis derives largely from expert opinion and case series instead of controlled trials, so treatment duration should be guided by clinical response and serial inflammatory markers. Document the absence of culture data clearly in the medical record and revisit the plan if the patient fails to improve within 48 to 72 hours.

What Do I Do When Ideal Surgical Resources, Such as Implants or Advanced Imaging, Are Unavailable?

Prioritize aggressive surgical debridement over technological adjuncts. Necrotic tissue and foreign material must be removed regardless of what imaging or fixation options exist, because antimicrobial therapy cannot penetrate avascular debris. When implant removal is not feasible, prolonged systemic therapy becomes necessary, and the expectation of remission instead of cure should guide client communication. Advanced imaging aids diagnosis but is not a prerequisite for treatment, clinical judgment and serial examination often suffice for superficial infections. Referral for specialised care should be discussed early when complex deep infections exceed local capability, as delayed definitive management worsens outcomes.

How Does Surgical Site Infection Management Differ Between Dogs, Cats, and Production Animals?

Dogs tolerate repeated wound manipulation and systemic antibiotics well, making aggressive multimodal therapy straightforward. Cats require more careful antimicrobial stewardship due to drug metabolism differences and heightened stress responses that impair wound healing. In production animals, treatment decisions must incorporate withdrawal periods, treatment costs relative to animal value, and herd-level implications. The MSD Veterinary Manual professional edition provides species-specific guidance on pharmacology and wound management. For food animals, consult regional regulatory standards such as the WOAH terrestrial animal health standards before initiating therapy, as residue avoidance and trade implications may override individual treatment preferences.

What Documentation Is Required for Surgical Site Infections, and Why Does It Matter?

Record the date of onset, clinical signs, wound classification, sampling method, culture results, antimicrobial choices with rationale, and serial assessments of response. Photographs provide objective documentation of wound progression. Accurate records support antimicrobial stewardship audits, identify emerging resistance patterns within the practice, and protect against medicolegal claims. If the infection is identified as potentially healthcare-associated, follow local reporting requirements. The AVMA practice resources offer guidance on medical record standards. Document client communication about expected outcomes, financial implications, and the possibility of prolonged treatment, particularly for deep infections where remission instead of cure is the realistic goal.

How Should I Explain a Surgical Site Infection to a Client Who Believes the Surgery Was Botched?

Lead with facts about the patient's current condition and the treatment plan, then address causation without defensiveness. Explain that surgical site infections occur despite strict aseptic technique because bacteria can enter through the incision, through hematogenous spread, or from the patient's own skin flora. Compare the risk to human surgical practice, where infections remain a recognized complication. Provide a clear timeline for expected improvement and be explicit about monitoring parameters that warrant re-evaluation. The ACVS animal health resources offer client-facing summaries that can supplement your explanation. Avoid assigning blame to any individual or protocol step unless a specific breach is documented.

When Should I Refer a Surgical Site Infection to a Specialist or Higher-Level Facility?

Refer when infection extends beyond the subcutaneous layer, involves bone, joint, or implanted hardware, or fails to respond to appropriate therapy within 72 hours. Deep infections require multidisciplinary management combining surgical debridement with prolonged antimicrobial therapy, and the evidence base for treatment duration remains limited, favouring centers with experience in complex wound care. Refer also when advanced imaging is needed to define the extent of infection, when the patient has comorbidities that complicate anesthesia, or when the practice lacks resources for repeated surgical procedures. Early referral is preferable to delayed transfer after failed attempts, as progression to systemic illness increases morbidity and cost.

Related Clinical & Scientific Guides

References and Further Reading

Related Articles

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.